Skip to main content
Clinical Trials/IRCT20210703051769N1
IRCT20210703051769N1
Completed
Phase 3

Assessment of effect of intravenus tranexamic acid on hemorrhage reduction during and after hysteretomy in comparison with control group

Esfahan University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Condition 1: Hysterectomy. Condition 2: Blood transfusion. Condition 3: Tranexamic acid.
Sponsor
Esfahan University of Medical Sciences
Enrollment
60
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Candidate of vaginal or abdominal hystrectomy
  • Between 35\-70 years old
  • American society of anesthesiologist (ASA) grade for physical status 1 or 2

Exclusion Criteria

  • Hepatic dysfunction
  • Renal dysfunction
  • Serious cardiac disease
  • Serious respiratory disease
  • Acquired or congenital coagulopathy
  • Previous history of deep venus thrombosis or thromboembolic disease
  • ASA more than 2
  • Sensitive to tranexamicacid

Outcomes

Primary Outcomes

Not specified

Similar Trials